135 related articles for article (PubMed ID: 38218206)
1. Arsenic in drinking water and lung cancer: A systematic review of 35 years of evidence.
Issanov A; Adewusi B; Saint-Jacques N; Dummer TJB
Toxicol Appl Pharmacol; 2024 Feb; 483():116808. PubMed ID: 38218206
[TBL] [Abstract][Full Text] [Related]
2. Bayesian benchmark dose analysis for inorganic arsenic in drinking water associated with bladder and lung cancer using epidemiological data.
Shao K; Zhou Z; Xun P; Cohen SM
Toxicology; 2021 May; 455():152752. PubMed ID: 33741492
[TBL] [Abstract][Full Text] [Related]
3. Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence.
Saint-Jacques N; Parker L; Brown P; Dummer TJ
Environ Health; 2014 Jun; 13():44. PubMed ID: 24889821
[TBL] [Abstract][Full Text] [Related]
4. Association between lung cancer risk and inorganic arsenic concentration in drinking water: a dose-response meta-analysis.
Yuan T; Zhang H; Chen B; Zhang H; Tao S
Toxicol Res (Camb); 2018 Nov; 7(6):1257-1266. PubMed ID: 30542608
[TBL] [Abstract][Full Text] [Related]
5. Relationships between arsenic concentrations in drinking water and lung and bladder cancer incidence in U.S. counties.
Mendez WM; Eftim S; Cohen J; Warren I; Cowden J; Lee JS; Sams R
J Expo Sci Environ Epidemiol; 2017 May; 27(3):235-243. PubMed ID: 27901016
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Review and Meta-Regression Analysis of Lung Cancer Risk and Inorganic Arsenic in Drinking Water.
Lamm SH; Ferdosi H; Dissen EK; Li J; Ahn J
Int J Environ Res Public Health; 2015 Dec; 12(12):15498-515. PubMed ID: 26690190
[TBL] [Abstract][Full Text] [Related]
7. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.
Lamm SH; Robbins SA; Zhou C; Lu J; Chen R; Feinleib M
Regul Toxicol Pharmacol; 2013 Feb; 65(1):147-56. PubMed ID: 23137931
[TBL] [Abstract][Full Text] [Related]
8. A dose-response meta-analysis of chronic arsenic exposure and incident cardiovascular disease.
Moon KA; Oberoi S; Barchowsky A; Chen Y; Guallar E; Nachman KE; Rahman M; Sohel N; D'Ippoliti D; Wade TJ; James KA; Farzan SF; Karagas MR; Ahsan H; Navas-Acien A
Int J Epidemiol; 2017 Dec; 46(6):1924-1939. PubMed ID: 29040626
[TBL] [Abstract][Full Text] [Related]
9. Arsenic in drinking water and kidney cancer: a systematic review.
Jaafarzadeh N; Poormohammadi A; Almasi H; Ghaedrahmat Z; Rahim F; Zahedi A
Rev Environ Health; 2023 Jun; 38(2):255-263. PubMed ID: 35286785
[TBL] [Abstract][Full Text] [Related]
10. Estimating the risk of bladder and kidney cancer from exposure to low-levels of arsenic in drinking water, Nova Scotia, Canada.
Saint-Jacques N; Brown P; Nauta L; Boxall J; Parker L; Dummer TJB
Environ Int; 2018 Jan; 110():95-104. PubMed ID: 29089168
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data.
Lynch HN; Zu K; Kennedy EM; Lam T; Liu X; Pizzurro DM; Loftus CT; Rhomberg LR
Environ Int; 2017 Sep; 106():178-206. PubMed ID: 28625818
[TBL] [Abstract][Full Text] [Related]
12. A Meta-analysis of Arsenic Exposure and Lung Function: Is There Evidence of Restrictive or Obstructive Lung Disease?
Sanchez TR; Powers M; Perzanowski M; George CM; Graziano JH; Navas-Acien A
Curr Environ Health Rep; 2018 Jun; 5(2):244-254. PubMed ID: 29637476
[TBL] [Abstract][Full Text] [Related]
13. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.
Tsuji JS; Alexander DD; Perez V; Mink PJ
Toxicology; 2014 Mar; 317():17-30. PubMed ID: 24462659
[TBL] [Abstract][Full Text] [Related]
14. Association of inorganic arsenic exposure with liver cancer mortality: A meta-analysis.
Wang W; Cheng S; Zhang D
Environ Res; 2014 Nov; 135():120-5. PubMed ID: 25262084
[TBL] [Abstract][Full Text] [Related]
15. Arsenic in drinking water and lung cancer: a systematic review.
Celik I; Gallicchio L; Boyd K; Lam TK; Matanoski G; Tao X; Shiels M; Hammond E; Chen L; Robinson KA; Caulfield LE; Herman JG; Guallar E; Alberg AJ
Environ Res; 2008 Sep; 108(1):48-55. PubMed ID: 18511031
[TBL] [Abstract][Full Text] [Related]
16. Case-control study of arsenic in drinking water and lung cancer in California and Nevada.
Dauphiné DC; Smith AH; Yuan Y; Balmes JR; Bates MN; Steinmaus C
Int J Environ Res Public Health; 2013 Aug; 10(8):3310-24. PubMed ID: 23917816
[TBL] [Abstract][Full Text] [Related]
17. Bladder cancer and arsenic through drinking water: a systematic review of epidemiologic evidence.
Christoforidou EP; Riza E; Kales SN; Hadjistavrou K; Stoltidi M; Kastania AN; Linos A
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2013; 48(14):1764-75. PubMed ID: 24007431
[TBL] [Abstract][Full Text] [Related]
18. A prospective cohort study of the association between drinking water arsenic exposure and self-reported maternal health symptoms during pregnancy in Bangladesh.
Kile ML; Rodrigues EG; Mazumdar M; Dobson CB; Diao N; Golam M; Quamruzzaman Q; Rahman M; Christiani DC
Environ Health; 2014 Apr; 13(1):29. PubMed ID: 24735908
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer in a U.S. population with low to moderate arsenic exposure.
Heck JE; Andrew AS; Onega T; Rigas JR; Jackson BP; Karagas MR; Duell EJ
Environ Health Perspect; 2009 Nov; 117(11):1718-23. PubMed ID: 20049123
[TBL] [Abstract][Full Text] [Related]
20. An updated systematic review and dose-response meta-analysis on the relation between exposure to arsenic and risk of type 2 diabetes.
Rahimi Kakavandi N; Mousavi T; Asadi T; Moradi A; Esmaeili M; Habibian Sezavar A; Nikfar S; Abdollahi M
Toxicol Lett; 2023 Aug; 384():115-127. PubMed ID: 37562716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
